{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:00:29Z","timestamp":1790424029914,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea National Research Counsil of Science & Technology","award":["CRC-16-01-KRICT"],"award-info":[{"award-number":["CRC-16-01-KRICT"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12985-018-1035-2","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T07:47:39Z","timestamp":1533714459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["Human \u03b2-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity"],"prefix":"10.1186","volume":"15","author":[{"given":"Ju","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Hee","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1675-4224","authenticated-orcid":false,"given":"Yong-Suk","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"key":"1035_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","volume":"15","author":"S Lee","year":"2015","unstructured":"Lee S, Nguyen MT. Recent advances of vaccine adjuvants for infectious diseases. Immune Netw. 2015;15:51\u20137.","journal-title":"Immune Netw"},{"key":"1035_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/vim.2017.0026","volume":"30","author":"T Aoshi","year":"2017","unstructured":"Aoshi T. Modes of action for mucosal vaccine adjuvants. Viral Immunol. 2017;30:463\u201370.","journal-title":"Viral Immunol"},{"key":"1035_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4110\/in.2017.17.5.326","volume":"17","author":"EJ Ko","year":"2017","unstructured":"Ko EJ, Lee YT, Lee Y, Kim KH, Kang SM. Distinct effects of monophosphoryl lipid a, oligodeoxynucleotide CpG, and combination adjuvants on modulating innate and adaptive immune responses to influenza vaccination. Immune Netw. 2017;17:326\u201342.","journal-title":"Immune Netw"},{"key":"1035_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/08830185.2013.773326","volume":"32","author":"E Kuroda","year":"2013","unstructured":"Kuroda E, Coban C, Ishii KJ. Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects. Int Rev Immunol. 2013;32:209\u201320.","journal-title":"Int Rev Immunol"},{"key":"1035_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000446282","volume":"59","author":"JI Casta\u00f1eda-S\u00e1nchez","year":"2016","unstructured":"Casta\u00f1eda-S\u00e1nchez JI, Dom\u00ednguez-Mart\u00ednez DA, Olivar-Espinosa N, Garc\u00eda-P\u00e9rez BE, Loro\u00f1o-Pino MA, Luna-Herrera J, Salazar MI. Expression of antimicrobial peptides in human monocytic cells and neutrophils in response to dengue virus type 2. Intervirology. 2016;59:8\u201319.","journal-title":"Intervirology"},{"key":"1035_CR6","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2174\/138161209788682325","volume":"15","author":"G Diamond","year":"2009","unstructured":"Diamond G, Beckloff N, Weinberg A, Kisich KO. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des. 2009;15:2377\u201392.","journal-title":"Curr Pharm Des"},{"key":"1035_CR7","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1016\/j.jmb.2013.09.038","volume":"425","author":"SS Wilson","year":"2013","unstructured":"Wilson SS, Wiens ME, Smith JG. Antiviral mechanisms of human defensins. J Mol Biol. 2013;425:4965\u201380.","journal-title":"J Mol Biol"},{"key":"1035_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.coi.2005.06.002","volume":"17","author":"JJ Oppenheim","year":"2005","unstructured":"Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol. 2005;17:359\u201365.","journal-title":"Curr Opin Immunol"},{"key":"1035_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.286.5439.525","volume":"286","author":"D Yang","year":"1999","unstructured":"Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schr\u00f6der JM, Wang JM, Howard OM, Oppenheim JJ. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999;286:525\u20138.","journal-title":"Science"},{"key":"1035_CR10","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1074\/jbc.271.6.2935","volume":"271","author":"O Chertov","year":"1996","unstructured":"Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ. Identification of defensin-1, defensin-2, and CAP37\/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem. 1996;271:2935\u201340.","journal-title":"J Biol Chem"},{"key":"1035_CR11","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1016\/j.vaccine.2014.08.086","volume":"32","author":"C Ma","year":"2014","unstructured":"Ma C, Wang L, Tao X, Zhang N, Yang Y, Tseng CK, Li F, Zhou Y, Jiang S, Du L. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments\u2013the importance of immunofocusing in subunit vaccine design. Vaccine. 2014;32:6170\u20136.","journal-title":"Vaccine"},{"key":"1035_CR12","doi-asserted-by":"publisher","first-page":"e8668","DOI":"10.1371\/journal.pone.0008668","volume":"5","author":"M Daigneault","year":"2010","unstructured":"Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One. 2010;5:e8668.","journal-title":"PLoS One"},{"key":"1035_CR13","doi-asserted-by":"publisher","first-page":"e81587","DOI":"10.1371\/journal.pone.0081587","volume":"8","author":"L Du","year":"2013","unstructured":"Du L, Kou Z, Ma C, Tao X, Wang L, Zhao G, Chen Y, Yu F, Tseng CT, Zhou Y, Jiang S. A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines. PLoS One. 2013;8:e81587.","journal-title":"PLoS One"},{"key":"1035_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1128\/JCM.02533-13","volume":"52","author":"X Lu","year":"2014","unstructured":"Lu X, Whitaker B, Sakthivel SK, Kamili S, Rose LE, Lowe L, Mohareb E, Elassal EM, Al-sanouri T, Haddadin A, Erdman DD. Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus. J Clin Microbiol. 2014;52:67\u201375.","journal-title":"J Clin Microbiol"},{"key":"1035_CR15","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1128\/JVI.03427-14","volume":"89","author":"AS Agrawal","year":"2015","unstructured":"Agrawal AS, Garron T, Tao X, Peng BH, Wakamiya M, Chan TS, Couch RB, Tseng CT. Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol. 2015;89:3659\u201370.","journal-title":"J Virol"},{"key":"1035_CR16","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/JVI.01702-06","volume":"81","author":"CT Tseng","year":"2007","unstructured":"Tseng CT, Huang C, Newman P, Wang N, Narayanan K, Watts DM, Makino S, Packard MM, Zaki SR, Chan TS, Peters CJ. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 virus receptor. J Virol. 2007;81:1162\u201373.","journal-title":"J Virol"},{"key":"1035_CR17","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1128\/JVI.02272-08","volume":"83","author":"N Yoshikawa","year":"2009","unstructured":"Yoshikawa N, Yoshikawa T, Hill Y, Huang C, Watts DM, Makino S, Milligan G, Chan T, Peters CJ, Tseng CT. Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2. J Virol. 2009;83:5451\u201365.","journal-title":"J Virol"},{"key":"1035_CR18","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1056\/NEJMoa043555","volume":"351","author":"RB Belshe","year":"2004","unstructured":"Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med. 2004;351:2286\u201394.","journal-title":"N Engl J Med"},{"key":"1035_CR19","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1128\/JVI.02035-08","volume":"83","author":"FS Quan","year":"2009","unstructured":"Quan FS, Yoo DG, Song JM, Clements JD, Compans RW, Kang SM. Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination. J Virol. 2009;83:4489\u201397.","journal-title":"J Virol"},{"key":"1035_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1600-065X.2011.01082.x","volume":"245","author":"RI Lehrer","year":"2012","unstructured":"Lehrer RI, Lu W. \u03b1-Defensins in human innate immunity. Immunol Rev. 2012;245:84\u2013112.","journal-title":"Immunol Rev"},{"key":"1035_CR21","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1016\/j.vaccine.2016.04.003","volume":"34","author":"RM Nandre","year":"2016","unstructured":"Nandre RM, Ruan X, Duan Q, Sack DA, Zhang W. Antibodies derived from an enterotoxigenic Escherichia coli (ETEC) adhesin tip MEFA (multiepitope fusion antigen) against adherence of nine ETEC adhesins: CFA\/I, CS1, CS2, CS3, CS4, CS5, CS6, CS21 and EtpA. Vaccine. 2016;34:3620\u20135.","journal-title":"Vaccine"},{"key":"1035_CR22","doi-asserted-by":"crossref","first-page":"e00550","DOI":"10.1128\/IAI.00550-17","volume":"86","author":"R Nandre","year":"2018","unstructured":"Nandre R, Ruan X, Lu T, Duan Q, Sack D, Zhang W. Enterotoxigenic Escherichia coli adhesin-toxoid multiepitope fusion antigen CFA\/I\/II\/IV-3xSTaN12S-mnLTG192G\/L211A-derived antibodies inhibit adherence of seven adhesins, neutralize enterotoxicity of LT and STa toxins, and protect piglets against diarrhea. Infect Immun. 2018;86:e00550\u201317.","journal-title":"Infect Immun"},{"key":"1035_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ni875","volume":"4","author":"SV Kotenko","year":"2003","unstructured":"Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2003;4:69\u201377.","journal-title":"Nat Immunol"},{"key":"1035_CR24","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1126\/science.8009221","volume":"264","author":"U M\u00fcller","year":"1994","unstructured":"M\u00fcller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264:1918\u201321.","journal-title":"Science"},{"key":"1035_CR25","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1099\/0022-1317-81-10-2341","volume":"81","author":"S Goodbourn","year":"2000","unstructured":"Goodbourn S, Didcock L, Randall RE. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol. 2000;81:2341\u201364.","journal-title":"J Gen Virol"},{"key":"1035_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.20506\/rst.17.1.1084","volume":"17","author":"O Haller","year":"1998","unstructured":"Haller O, Frese M, Kochs G. Mx proteins: mediators of innate resistance to RNA viruses. Rev Sci Technol. 1998;17:220\u201330.","journal-title":"Rev Sci Technol"},{"key":"1035_CR27","doi-asserted-by":"publisher","first-page":"41701","DOI":"10.1074\/jbc.M206473200","volume":"277","author":"O Gutierrez","year":"2002","unstructured":"Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F, Nunez G, Fernandez-Luna JL. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem. 2002;277:41701\u20135.","journal-title":"J Biol Chem"},{"key":"1035_CR28","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1126\/science.1104911","volume":"307","author":"KS Kobayashi","year":"2005","unstructured":"Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nu\u00f1ez G, Flavell RA. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731\u20134.","journal-title":"Science"},{"key":"1035_CR29","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/ni.1782","volume":"10","author":"A Sabbah","year":"2009","unstructured":"Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, Xiang Y, Bose S. Activation of innate immune antiviral responses by Nod2. Nat Immunol. 2009;10:1073\u201380.","journal-title":"Nat Immunol"},{"key":"1035_CR30","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1074\/jbc.M008072200","volume":"276","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1\/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem. 2001;276:4812\u20138.","journal-title":"J Biol Chem"},{"key":"1035_CR31","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/gut.52.11.1591","volume":"52","author":"Y Ogura","year":"2003","unstructured":"Ogura Y, Lala S, Xin W, Smith E, Dowds TA, Chen FF, Zimmermann E, Tretiakova M, Cho JH, Hart J, Greenson JK, Keshav S, Nu\u00f1ez G. Expression of NOD2 in Paneth cells: a possible link to Crohn\u2019s ileitis. Gut. 2003;52:1591\u20137.","journal-title":"Gut"},{"key":"1035_CR32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/intimm\/12.5.691","volume":"12","author":"K Tani","year":"2000","unstructured":"Tani K, Murphy WJ, Chertov O, Salcedo R, Koh CY, Utsunomiya I, Funakoshi S, Asai O, Herrmann SH, Wang JM, Kwak LW, Oppenheim JJ. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol. 2000;12:691\u2013700.","journal-title":"Int Immunol"},{"key":"1035_CR33","doi-asserted-by":"crossref","first-page":"ii17","DOI":"10.1136\/ard.62.suppl_2.ii17","volume":"62 Suppl 2","author":"JJ Oppenheim","year":"2003","unstructured":"Oppenheim JJ, Biragyn A, Kwak LW, Yang D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis. 2003;62 Suppl 2:ii17\u201321.","journal-title":"Ann Rheum Dis"},{"key":"1035_CR34","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.4049\/jimmunol.167.11.6644","volume":"167","author":"A Biragyn","year":"2001","unstructured":"Biragyn A, Surenhu M, Yang D, Ruffini PA, Haines BA, Klyushnenkova E, Oppenheim JJ, Kwak LW. Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J Immunol. 2001;167:6644\u201353.","journal-title":"J Immunol"},{"key":"1035_CR35","doi-asserted-by":"publisher","first-page":"6688","DOI":"10.4049\/jimmunol.0903984","volume":"184","author":"J R\u00f6hrl","year":"2010","unstructured":"R\u00f6hrl J, Yang D, Oppenheim JJ, Hehlgans T. Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol. 2010;184:6688\u201394.","journal-title":"J Immunol"},{"key":"1035_CR36","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1126\/science.1075565","volume":"298","author":"A Biragyn","year":"2002","unstructured":"Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, Kwak LW. Toll-like receptor 4-dependent activation of dendritic cells by \u03b2-defensin 2. Science. 2002;298:1025\u20139.","journal-title":"Science"},{"key":"1035_CR37","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1189\/jlb.1007700","volume":"83","author":"A Biragyn","year":"2008","unstructured":"Biragyn A, Coscia M, Nagashima K, Sanford M, Young HA, Olkhanud P. Murine beta-defensin 2 promotes TLR-4\/MyD88-mediated and NF-\u03baB-dependent atypical death of APCs via activation of TNFR2. J Leukoc Biol. 2008;83:998\u20131008.","journal-title":"J Leukoc Biol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-1035-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-018-1035-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-1035-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T03:40:09Z","timestamp":1751773209000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-018-1035-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1186\/s12985-018-1035-2","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,8]]},"assertion":[{"value":"12 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were approved by the Institutional Animal Care and Use Committee of Chonbuk National University (Approval No. CBNU 2017\u20130055) and followed the guidelines suggested by the committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"124"}}